Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.-Reference-Cited by-同舟云学术

Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.

Published:1982-09-01 Issue:3 Volume:48 Page:304-305
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

Baron M,Skrinskas G,Hyland R,Urowitz M B

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. Haemodynamic effects of prostacyclin (PG12) in pulmonary hypertension;Guadagni, D.N.; Ikram, H.; Maslowski, A.H.;Br Heart J,1981

2. change in pulmonary pressure. PGE1 is not as Levine L. Prostacyclin and prostaglandin El for severe idiopathic pulmonary artery hypertension (letter);Watkins, W.D.; Peterson, M.B.; Crone, R.K.; Shannon, D.C.;Lancet,1980

3. Effects of prostaglandin El on pulmonary circulation in patients with pulmonary hypertension;Szczeklik, J.; Dubiel, J.S.; Mysik, M.; Pyzik, Z.; Krol, R.; Horzela, T.;Br HeartJ,1978

4. for pulmonary hypertension (letter). Lancet 1980

5. Observations on the effects of infusion of Prostaglandin E in man;Bergstrom, S.; Duner, H.; Von Euler, U.S.; Pernow, B.; Sjovall, J.;Acta Physiol Scand,1959

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atteinte pulmonaire au cours de la sclérodermie systémique. Partie II. Hypertension artérielle pulmonaire isolée, cancer bronchopulmonaire, hémorragie alvéolaire;La Revue de Médecine Interne;1999-11

2. MANIFESTATIONS OF SCLERODERMA PULMONARY DISEASE;Clinics in Chest Medicine;1998-12

3. CLINICAL PROBLEMS;Rheumatic Disease Clinics of North America;1996-11

4. Lung disease in systemic sclerosis (scleroderma);Baillière's Clinical Rheumatology;1993-02

5. Pharmacologic Treatment of Primary and Secondary Pulmonary Hypertension;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;1991-03-04